4.4 Article

Evodiamine inhibits malignant progression of ovarian cancer cells by regulating lncRNA-NEAT1/miR-152-3p/CDK19 axis

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Synthesis of ring opening of evodiamine derivatives and evaluation on their biological activity

Weihang Guo et al.

Summary: Evodiamine, extracted from Evodiae fructus, was used as starting material to synthesize novel ring-opening derivatives, which showed moderate to good antitumor activity in vitro. Among them, the hexyl substituted evodiamine derivative demonstrated strong antitumor activity against BGC803 and SW480 cells.

CHEMICAL BIOLOGY & DRUG DESIGN (2022)

Article Biotechnology & Applied Microbiology

Neat1 promotes acute kidney injury to chronic kidney disease by facilitating tubular epithelial cells apoptosis via sequestering miR-129-5p

Tongtong Ma et al.

Summary: In this study, it was discovered through high-throughput RNA sequencing that Neat1_2, a transcript variant of Neat1, was upregulated in acute kidney injury (AKI) and played a role in promoting apoptosis of injured tubular epithelial cells, resulting in tubulointerstitial inflammation and fibrosis. This effect was mediated by the competitive binding of Neat1_2 to miR-129-5p, which prevented miR-129-5p from decreasing the levels of FADD, CASP-8, and CASP-3.

MOLECULAR THERAPY (2022)

Article Oncology

WZY-321 triggers glioma cell apoptosis via XAF1 up-regulation caused by MTM-mediated miR-873 down-regulation

Guan Sun et al.

Summary: WZY-321 induces glioma cell apoptosis by up-regulating XAF1 expression and down-regulating miR-873 expression. This study helps to understand the mechanism of action of WZY-321 and provides new insights for the treatment of gliomas.

JOURNAL OF CANCER (2022)

Article Plant Sciences

Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway

Xiao Xu et al.

Summary: The combination of Hedyotis diffusa Willd and Scutellaria barbata D.Don (HD-SB) has been traditionally used for its anti-tumor effects. This study found that HD-SB significantly inhibited the proliferation and migration of ovarian cancer cells, mainly through the focal adhesion pathway. Quercetin, luteolin, and baicalein were identified as important anti-ovarian cancer ingredients in HD-SB.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Article Chemistry, Medicinal

Design, synthesis, and biological evaluation of 3′,4′,5′-trimethoxy evodiamine derivatives as potential antitumor agents

Yijiao Peng et al.

Summary: A series of compounds with 3', 4', 5'-trimethoxy module incorporated into the core structure of evodiamine were synthesized and screened for their antitumor potential. Among them, compound 14h showed the most significant inhibitory effects on cell proliferation and migration, and could potentially be a drug candidate for the treatment of gastric cancer. Further experiments confirmed its mechanism of action and potential therapeutic value.

DRUG DEVELOPMENT RESEARCH (2021)

Review Biochemistry & Molecular Biology

Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component

Jingyuan Wu et al.

Summary: Ovarian cancer ranks seventh among female malignant tumors, threatening reproductive health with a high recurrence rate and poor prognosis. Botanical compounds show unique advantages in reducing tumor burden and improving treatment quality, potentially serving as an auxiliary option for managing ovarian cancer.

MOLECULES (2021)

Article Medicine, Research & Experimental

Lnc-NEAT1 induces cell apoptosis and inflammation but inhibits proliferation in a cellular model of hepatic ischemia/reperfusion injury

Liu Wang et al.

Summary: The study revealed that overexpression of lnc-NEAT1 in hepatic ischemia/reperfusion injury model induced cell apoptosis and inflammation while inhibiting cell proliferation. Targeted interference of lnc-NEAT1 can reduce apoptosis rate and inflammatory cytokine expression, promoting liver cell proliferation.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2021)

Review Medical Laboratory Technology

LncRNAs in ovarian cancer

Jin-yan Wang et al.

CLINICA CHIMICA ACTA (2019)

Review Oncology

Ovarian Cancer: An Integrated Review

Christine Stewart et al.

SEMINARS IN ONCOLOGY NURSING (2019)

Article Cell Biology

Identifying Cancers Impacted by CDK8/19

Igor B. Roninson et al.

CELLS (2019)

Article Medicine, Research & Experimental

miR-152 is involved in the proliferation and metastasis of ovarian cancer through repression of ERBB3

Lian-Wei Li et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)

Review Cell Biology

miRNAs and ovarian cancer: An overview

Bornali Deb et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

Review Oncology

A comprehensive review of protein kinase inhibitors for cancer therapy

Radhamani Kannaiyan et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2018)

Review Biochemistry & Molecular Biology

Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives

Xu Hu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biochemistry & Molecular Biology

Protein kinases that phosphorylate splicing factors: Roles in cancer development, progression and possible therapeutic options

Alicja Czubaty et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)

Article Oncology

Real-world evidence in the treatment of ovarian cancer

E. A. Eisenhauer

ANNALS OF ONCOLOGY (2017)

Article Oncology

Acquired chemotherapy resistance in ovarian cancer

E. L. Christie et al.

ANNALS OF ONCOLOGY (2017)

Article Obstetrics & Gynecology

Epidemiology of epithelial ovarian cancer

Penelope M. Webb et al.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2017)

Review Biotechnology & Applied Microbiology

The history and future of targeting cyclin-dependent kinases in cancer therapy

Uzma Asghar et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Review Biochemistry & Molecular Biology

Pharmacological Actions of Multi-Target-Directed Evodiamine

Hui Yu et al.

MOLECULES (2013)